- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
The Reagan-Udall Foundation for the FDA (the Foundation) seeks nominations for its annual Innovations in Regulatory Science & Policy Awards.
Coverage
I want to highlight a new article, “Primary mitochondrial diseases: A rare disease virtual workshop,” which distills key insights from the Reagan‑Udall Foundation for the FDA and FDA virtual workshop held on May 22, 2025.
The Reagan-Udall Foundation for the Food and Drug Administration isn’t exactly a unicorn among nonprofits—but it is something of a zebra.
Ketamine Statistics: Ketamine is a dissociative anesthetic primarily used in surgical settings for its rapid onset and pain relief properties.